Evaluation of tumor antigen-specific antibody responses in patients with metastatic triple negative breast cancer treated with cyclophosphamide and pembrolizumab

The role of B cells in antitumor immunity is becoming increasingly appreciated, as B cell populations have been associated with response to immune checkpoint blockade (ICB) in patients with breast cancer and murine models of breast cancer. Deeper understanding of antibody responses to tumor antigens...

Descripción completa

Detalles Bibliográficos
Autores principales: Routh, Eric D, Woodcock, Mark G, Beckabir, Wolfgang, Vensko, Steven P, Serody, Jonathan S, Vincent, Benjamin G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Immunotherapy Biomarkers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10008414/
https://www.ncbi.nlm.nih.gov/pubmed/36882226
http://dx.doi.org/10.1136/jitc-2022-005848

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10008414/
https://www.ncbi.nlm.nih.gov/pubmed/36882226
http://dx.doi.org/10.1136/jitc-2022-005848

Ejemplares similares